Quick Answer
CYTOKINETICS INC reported Stockholders Equity of -$659.63 million for the year ending 2025.
- CYTOKINETICS INC showed a decrease of -387.3% in Stockholders Equity from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $86.18 million | Q2 2014: $78.70 million | Q3 2014: $73.63 million | Q1 2015: $84.15 million | Q2 2015: $74.86 million | Q3 2015: $67.30 million | Q1 2016: $57.91 million | Q2 2016: $48.75 million | Q3 2016: $83.25 million | Q1 2017: $95.38 million | Q2 2017: $175.00 million | Q3 2017: $147.04 million | Q1 2018: $99.60 million | Q2 2018: $75.17 million | Q3 2018: $52.07 million | Q1 2019: $3.37 million | Q2 2019: -$4.90 million | Q3 2019: -$19.87 million | Q1 2020: -$45.71 million | Q2 2020: -$78.08 million | Q3 2020: $149.61 million | Q1 2021: $67.85 million | Q2 2021: $16.49 million | Q3 2021: $249.02 million | Q1 2022: $116.26 million | Q2 2022: $111.41 million | Q3 2022: -$15.98 million | Q1 2023: -$229.02 million | Q2 2023: -$333.12 million | Q3 2023: -$438.80 million | Q1 2024: -$396.16 million | Q2 2024: $108.55 million | Q3 2024: -$13.91 million | Q1 2025: -$266.41 million | Q2 2025: -$368.72 million | Q3 2025: -$521.12 million.
- Over the full 15 years of available data (2011 to 2025), CYTOKINETICS INC's Stockholders Equity has declined by 1,469.1%.
- Historical annual values: Fiscal year 2025: -$659.63 million | Fiscal year 2024: -$135.37 million | Fiscal year 2023: -$386.32 million | Fiscal year 2022: -$107.90 million | Fiscal year 2021: $243.86 million | Fiscal year 2020: $113.38 million | Fiscal year 2019: -$10.94 million | Fiscal year 2018: $25.93 million | Fiscal year 2017: $109.84 million | Fiscal year 2016: $94.36 million | Fiscal year 2015: $68.59 million | Fiscal year 2014: $92.06 million | Fiscal year 2013: $54.44 million | Fiscal year 2012: $70.09 million | Fiscal year 2011: $48.18 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: